The Key to Finding the Right Leader is Knowing our Clients.

We have been privileged to partner with initial start-ups, development stage companies and global leaders in the life sciences sector. Each client brings unique and compelling aspects, and we have developed an outstanding ability to find the right candidates who fit best with their needs.



At Trevena, our mission is to deliver innovative solutions to patients and healthcare providers confronting serious medical conditions. Our lead product candidate is OLINVO (oliceridine injection), an innovative new chemical entity that has recently completed Phase 3 pivotal efficacy studies for the management of moderate-to-severe acute pain. OLINVO is designated a Breakthrough Therapy by the U.S. Food and Drug Administration. We also have discovered several other product candidates with the potential to address problems across a wide range of therapeutic areas, including moderate-to-severe acute and chronic pain, and acute episodic migraine. In addition, we have an early-stage portfolio of drug discovery programs currently in lead optimization.

Search Projects